Worth over $30 billion, therapeutic proteins, produced by recombinant mammalian cells, have been the fastest growing class of medicines in industrialized nations. Their importance in the health industry in the next decade will be ever greater as their reach expands, improving the quality of life of millions. Critical to the quality of the manufactured product and the robustness of the process is the producing cell. Over three quarters of these products are produced by CHO cells. Advances in DNA sequencing technology in the past few years have afforded the possibility of decoding the entire genome of these cells. Armed with the genome sequence information, one can contemplate specifically altering their sequence and even modifying their genome. This presentation will review genome and sequencing basics, highlight genome information processing, exemplify sequence utility and envision the potential impact of the genome on process advancement and innovation.
Would you like to access this content?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
You must be logged in to view this content. Log in now.
You must purchase this webinar using one of the options below.
If you already purchased this content recently, please click here to refresh the system's record of ownerships.
|Credits||1 Use credits|
|List Price||$99.00 Buy now|
|AIChE Members||$69.00 Buy now|
|AIChE Undergraduate Student Members||Free Free access|
|AIChE Graduate Student Members||Free Free access|
|SBE Members||Free Free access|